TGTao Gong

Tao Gong

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Tao Gong has a total of 97 co-authors. Here are the top co-authors by number of shared publications:

  • Rongbin Zhou

    Key Laboratory of Immune Response and Immunotherapy, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China

    10 shared publications
  • Wei Jiang

    Key Laboratory of Immune Response and Immunotherapy, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China

    8 shared publications
  • Yanqing Yang

    Department of Clinical Laboratory, the First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, China

    5 shared publications
  • Andrea Cavalli

    Institute for Research in Biomedicine, Università della Svizzera Italiana, Bellinzona, Switzerland

    2 shared publications
  • Davide F. Robbiani

    Institute for Research in Biomedicine, Università della Svizzera Italiana, 6500 Bellinzona, Switzerland

    2 shared publications
  • Jacopo Sgrignani

    Institute for Research in Biomedicine (IRB), Via Chiesa 5, 6500 Bellinzona, Switzerland

    2 shared publications

Latest Publications

  • Aberrant expression of HERV-K envelope in lymphoma represents an opportunity for novel treatments.

    by Filippo Spriano, Luciano Cascione, Jacopo Sgrignani, Nikolai Bendik, Alex Zadro, Sara Napoli, Giulio Sartori, Concetta Guerra, Eleonora Cannas, Tao Gong, et al.

    Purpose: Human endogenous retrovirus K (HERV-K/HML-2) is a human-specific endogenous retrovirus family that maintains intact open reading frames and is aberrantly expressed in multiple cancers. We tested whether HERV-K, specifically its envelope (Env) protein, marks clinically relevant diffuse large B-cell lymphoma (DLBCL) states and serves as a tractable immunotherapeutic target. Experimental Design: Locus-level transposable element (TE) and HERV expression was quantified in two independent DLBCL RNA-seq cohorts using curated TE annotation and a uniform alignment/counting workflow. Env transcript and protein expression (including cell-surface localization) was validated in lymphoma cell lines using RT-qPCR, immunoblotting, and flow cytometry. Functional relevance was assessed by siRNA-mediated Env knockdown. Candidate extracellular linear epitopes were predicted in silico and synthesized for serological and phage display assays. Anti-Env camelid VHHs were isolated, humanized, and tested for binding, antibody-dependent cellular cytotoxicity (ADCC), and antigen-dependent internalization. Results: TE transcripts stratified DLBCL into clinically distinct subgroups, and high HERV-K expression associated with an interferon/viral-mimicry program. Env RNA was detected in patient tumors and cell lines, and the protein was detected on the surface of a subset of lymphoma cell lines, in which Env knockdown reduced proliferation. A humanized heavy-chain antibody (FF-01) bound surface Env, induced selective ADCC in Env-positive models (reporter and primary NK-cell assays), and underwent rapid antigen-dependent internalization. Conclusions: HERV-K activity identifies biologically meaningful DLBCL states and exposes a targetable surface antigen. FF-01 provides proof of principle for antibody-based strategies against HERV-K Env, including ADCC- and ADC-oriented approaches.

  • Open Access

    Anti-chemokine antibodies after SARS-CoV-2 infection correlate with favorable disease course

    by Jonathan Muri, Valentina Cecchinato, Andrea Cavalli, Akanksha A. Shanbhag, Milos Matkovic, Maira Biggiogero, Pier Andrea Maida, Jacques Moritz, Chiara Toscano, Elaheh Ghovehoud, et al.

    Infection by SARS-CoV-2 leads to diverse symptoms, which can persist for months. While antiviral antibodies are protective, those targeting interferons and other immune factors are associated with adverse COVID-19 outcomes. Instead, we discovered that antibodies against specific chemokines are omnipresent after COVID-19, associated with favorable disease, and predictive of lack of long COVID symptoms at one year post infection. Anti-chemokine antibodies are present also in HIV-1 infection and autoimmune disorders, but they target different chemokines than those in COVID-19. Monoclonal antibodies derived from COVID- 19 convalescents that bind to the chemokine N-loop impair cell migration. Given the role of chemokines in orchestrating immune cell trafficking, naturally arising anti-chemokine antibodies associated with favorable COVID-19 may be beneficial by modulating the inflammatory response and thus bear therapeutic potential. One-Sentence Summary: Naturally arising anti-chemokine antibodies associate with favorable COVID-19 and predict lack of long COVID.


  • Synthetic vitamin K analogs inhibit inflammation by targeting the NLRP3 inflammasome

    by Xicui Zheng, Yingting Hou, Hongbin He, Yun Chen, Rongbin Zhou, Xiaqiong Wang, Tao Gong, Wei Jiang

    Vitamin K refers to a group of structurally similar vitamins that are essential for proper blood coagulation, as well as bone and cardiovascular health. Previous studies have indicated that vitamin K may also have anti-inflammatory properties, although the underlying mechanisms of its anti-inflammatory effects remain unclear. The NLRP3 inflammasome is a multiprotein complex, and its activation leads to IL-1β and IL-18 secretion and contributes to the pathogenesis of various human inflammatory diseases. Here, we show that synthetic vitamins K3 and K4 are selective, potent inhibitors of the NLRP3 inflammasome and specifically block the interaction between NLRP3 and ASC, thereby inhibiting NLRP3 inflammasome assembly. Moreover, we show that treatment with vitamin K3 or K4 attenuates the severity of inflammation in a mouse model of peritonitis. Our results demonstrate that vitamins K3 and K4 exert their anti-inflammatory effects by inhibiting NLRP3 inflammasome activation and indicate that vitamin K supplementation may be a treatment option for NLRP3-associated inflammatory diseases.


  • Golgi Apparatus: An Emerging Platform for Innate Immunity

    by Ye Tao, Yanqing Yang, Rongbin Zhou, Tao Gong


  • Commensal viruses maintain intestinal intraepithelial lymphocytes via noncanonical RIG-I signaling

    by Lei Liu, Tao Gong, Wanyin Tao, Bolong Lin, Cong Li, Xuesen Zheng, Shu Zhu, Wei Jiang, Rongbin Zhou

    Much attention has focused on commensal bacteria in health and disease, but the role of commensal viruses is understudied. Although metagenomic analysis shows that the intestine of healthy humans and animals harbors various commensal viruses and the dysbiosis of these viruses can be associated with inflammatory diseases, there is still a lack of causal data and underlying mechanisms to understand the physiological role of commensal viruses in intestinal homeostasis. In the present study, we show that commensal viruses are essential for the homeostasis of intestinal intraepithelial lymphocytes (IELs). Mechanistically, the cytosolic viral RNA-sensing receptor RIG-I in antigen-presenting cells can recognize commensal viruses and maintain IELs via a type I interferon–independent, but MAVS-IRF1-IL-15 axis-dependent, manner. The recovery of IELs by interleukin-15 administration reverses the susceptibility of commensal virus-depleted mice to dextran sulfate sodium–induced colitis. Collectively, our results indicate that commensal viruses maintain the IELs and consequently sustain intestinal homeostasis via noncanonical RIG-I signaling.


  • Top Cited Papers

    DAMP-sensing receptors in sterile inflammation and inflammatory diseases

    by Tao Gong, Lei Liu, Wei Jiang, Rongbin Zhou

    The innate immune system has the capacity to detect ‘non-self’ molecules derived from pathogens, known as pathogen-associated molecular patterns, via pattern recognition receptors. In addition, an increasing number of endogenous host-derived molecules, termed damage-associated molecular patterns (DAMPs), have been found to be sensed by various innate immune receptors. The recognition of DAMPs, which are produced or released by damaged and dying cells, promotes sterile inflammation, which is important for tissue repair and regeneration, but can also lead to the development of numerous inflammatory diseases, such as metabolic disorders, neurodegenerative diseases, autoimmune diseases and cancer. Here we examine recent discoveries concerning the roles of DAMP-sensing receptors in sterile inflammation and in diseases resulting from dysregulated sterile inflammation, and then discuss insights into the cross-regulation of these receptors and their ligands.


  • NLRP2 negatively regulates antiviral immunity by interacting with TBK1

    by Yanqing Yang, Xueting Lang, Song Sun, Chun Gao, Jianguo Hu, Shuqin Ding, Jing Li, Yuyun Li, Fengchao Wang, Tao Gong

    Nucleotide‐binding oligomerization domain (NOD)‐like receptors (NLRs) are intracellular pattern recognition receptors (PRRs) that regulate a variety of inflammatory and host defense responses. Unlike the well‐established NLRs, the roles of NLRP2 are controversial and poorly defined. Here, we report that NLRP2 acts as a negative regulator of TANK‐binding kinase 1 (TBK1)‐mediated type I interferon (IFN) signaling. Mechanistically, NLRP2 interacted directly with TBK1, and this binding disrupted the interaction of TBK1 and interferon regulatory factor 3 (IRF3), which interfered with TBK1‐induced IRF3 phosphorylation. IFNs induce a series of proteins that have well‐known antiviral or immune‐regulatory functions, and tight control of the IFN signaling cascade is critical for limiting tissue damage and preventing autoimmunity. Our studies indicate that the NLRP2‐TBK1 axis may serve as an additional signaling cascade to maintain immune homeostasis in response to viral infection.